The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion.
Recruiting · NCT06984731 · Observational (researchers observe without assigning treatment) · Lead sponsor: Affiliated Hospital of Nantong University
View the official record on ClinicalTrials.gov →Interventions studied
left atrial appendage closureradiofrequency ablation
What this trial is about
Objective: To evaluate the safety and efficacy of transcatheter atrial fibrillation ablation 1 month after WATCHMAN FLX left atrial appendage closure in patients with nonvalvular atrial fibrillation.
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- ≥18 years of age, diagnosed with nonvalvular atrial fibrillation;
- Meet the indications for receiving WATCHMAN FLX left atrial appendicular closure and transcatheter atrial fibrillation ablation;
- Preoperative imaging evaluation showed that the anatomical structure of the left atrial appendage was suitable for implantation with the WATCHMAN FLX device;
- The patient agrees to participate in the study and signs the informed consent.
Exclusion criteria
- valvular heart disease or other structural heart disease that causes atrial fibrillation;
- left auricular thrombus or acute thrombotic event was found before surgery;
- Patients with severe bleeding tendency or recent major bleeding events (such as massive gastrointestinal bleeding, cerebral hemorrhage, etc.);
- Patients who are unable to complete postoperative follow-up (such as life expectancy of less than 1 year or poor compliance);
- Other serious diseases (such as liver and kidney failure, active infection, etc.) were found in preoperative examination;
- Pregnant or lactating women.
Where it is running
1 location listed.
- Affiliated hospital of Nantong University - Nantong, Jiangsu, China